APA (7th ed.) Citation

Böhm, M., Anker, S., Butler, J., Filippatos, G., Ferreira, J. P., Pocock, S. J., . . . Packer, M. (2021). Empagliflozin improves cardiovascular and renal outcomes in heart failure irrespective of systolic blood pressure. Journal of the American College of Cardiology, 78(13), . https://doi.org/10.1016/j.jacc.2021.07.049

Chicago Style (17th ed.) Citation

Böhm, Michael, et al. "Empagliflozin Improves Cardiovascular and Renal Outcomes in Heart Failure Irrespective of Systolic Blood Pressure." Journal of the American College of Cardiology 78, no. 13 (2021). https://doi.org/10.1016/j.jacc.2021.07.049.

MLA (9th ed.) Citation

Böhm, Michael, et al. "Empagliflozin Improves Cardiovascular and Renal Outcomes in Heart Failure Irrespective of Systolic Blood Pressure." Journal of the American College of Cardiology, vol. 78, no. 13, 2021, https://doi.org/10.1016/j.jacc.2021.07.049.